Pathology Core
病理学核心
基本信息
- 批准号:7729379
- 负责人:
- 金额:$ 14.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-04 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:AscitesBenignBiopsy SpecimenBloodCancer CenterClinicalCollectionCystDatabasesDiagnosticDoctor of MedicineFormalinFreezingFutureGoalsImmunohistochemistryIn Situ HybridizationIndividualIntranetLiquid substanceMalignant neoplasm of ovaryMicrodissectionNormal tissue morphologyOperative Surgical ProceduresOvarianOvarian DiseasesOvarian TissueOvaryParaffin EmbeddingParaffin TissuePathologistPathologyPatientsProcessPrognostic MarkerReproduction sporesResearch PersonnelResearch Project GrantsResourcesSamplingServicesSlideSourceSpecimenStagingTestingTissue MicroarrayTissuesTumor BankUniversitiesUrinebaseendometriosisexperienceprognosticrepositoryresearch studytumorvirtual
项目摘要
The individual research projects that make up this Ovarian Cancer SPORE application require the
procurement, processing, and analysis of histopathological material from patients with ovarian cancer and
benign ovarian diseases. The research projects have needs for frozen and formalin-fixed, paraffinembedded
samples of tumor and normal tissue. The Pathology Core augments the already established
M.D. Anderson Cancer Center Gynecological Tumor Bank and the P30-sponsored M.D. Anderson Cancer
Center Centralized Tissue Repository with supporting database and intranet access. The Core provides
tissue acquisition by experienced gynecological pathologists to assure high-quality tissues for the
investigators participating in this SPORE as well as investigators of other SPOREs.
The goal of the Pathology Core is to provide frozen tissue, paraffin-embedded tissue, and histopathological
expertise related to the specific needs for the research projects comprising this SPORE proposal. To
achieve this goal, the Pathology Core has the following Specific Aims. Aim 1 is to maintain a frozen and
paraffin-embedded tissue repository of ovarian cancer, benign ovarian processes, and normal ovary. The
primary tissue source is operative and biopsy specimens submitted to the Department of Pathology at M.D.
Anderson Cancer Center. In addition, a subcontract with Duke University provides additional ovarian
tissues, particularly early stage ovarian cancers. Aim 2 is to provide pathological review for all clinical
specimens utilized in the SPORE projects and to provide histopathological technical services as necessary.
Such technical services include immunohistochemistry, in situ hybridization, creation of specific tissue
microarray slides, and microdissection of tissue sections. Aim 3 is to establish a blood/urine/ascites fluid
repository from patients undergoing surgery for ovarian cancer and benign ovarian processes. These fluids
provide the resources for the systemic testing of putative prognostic and diagnostic markers derived from
tissue-based expression array and CGH experiments. Aim 4 is to create and maintain a SPORE Database
for all samples collected at both M.D. Anderson Cancer Center and Duke University. This SPORE Database
is a virtual tissue repository that is electronically shared by all SPORE investigators.
组成这个卵巢癌孢子应用程序的个人研究项目需要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUSSELL R BROADDUS其他文献
RUSSELL R BROADDUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUSSELL R BROADDUS', 18)}}的其他基金
Strategy for the Incorporation of Tissue Biomarkers in the Clinical Management of
将组织生物标志物纳入临床管理的策略
- 批准号:
7962011 - 财政年份:2010
- 资助金额:
$ 14.45万 - 项目类别:
P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma
P2:CTNNB1 突变和 Wnt 通路激活定义临床侵袭性子宫内膜样子宫内膜癌
- 批准号:
10006204 - 财政年份:2003
- 资助金额:
$ 14.45万 - 项目类别:
MD Anderson Gynecologic SPORE for Uterine Cancers
MD 安德森妇科 SPORE 治疗子宫癌
- 批准号:
10006057 - 财政年份:2003
- 资助金额:
$ 14.45万 - 项目类别:
MD Anderson Gynecologic SPORE for Uterine Cancers
MD 安德森妇科 SPORE 治疗子宫癌
- 批准号:
10249382 - 财政年份:2003
- 资助金额:
$ 14.45万 - 项目类别:
P2: CTNNB1 Mutation and Wnt Pathway Activation Define Clinically Aggressive Endometrioid Endometrial Carcinoma
P2:CTNNB1 突变和 Wnt 通路激活定义临床侵袭性子宫内膜样子宫内膜癌
- 批准号:
10265741 - 财政年份:2003
- 资助金额:
$ 14.45万 - 项目类别:
相似海外基金
Genome analysis-based prediction model development for response to stereotactic radiosurgery in benign brain tumors
基于基因组分析的预测模型开发,用于良性脑肿瘤立体定向放射外科治疗的反应
- 批准号:
23K08495 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
- 批准号:
22KJ2498 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
良性泌尿外科、良性肾脏病学和非癌症血液学领域的学习者和领导者
- 批准号:
10726042 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
- 批准号:
10607151 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
Development of a medical device to resolve benign esophageal stricture by heating and traction
开发通过加热和牵引解决良性食管狭窄的医疗设备
- 批准号:
23H03765 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of benign/malignant differentiation method for thyroid follicular tumor using organoids
利用类器官开发甲状腺滤泡性肿瘤良恶性鉴别方法
- 批准号:
23K08075 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
p53在散发性肿瘤发生良性向恶性转变中的参与和作用机制
- 批准号:
10720034 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 14.45万 - 项目类别:
Standard Grant
Towards Achieving Zero Emissions through the use of an Environmentally Benign Non-Regenerable Solvent to Capture CO2 from Large Point Source Emitters for Direct Permanent Storage in Geological Formation or Usage in Accelerated Curing of Ready-mix Con
通过使用环境友好的不可再生溶剂从大型点源排放器捕获二氧化碳,直接永久储存在地质构造中或用于预拌混凝土的加速固化,从而实现零排放
- 批准号:
RGPIN-2022-03431 - 财政年份:2022
- 资助金额:
$ 14.45万 - 项目类别:
Discovery Grants Program - Individual